New ETF Book by Larry Connors - Click here to read more
The e-Pathologist system uses "machine intelligence" to detect tissue and cell features and make quantitative measurements of key structures in digitized images of slides of tissue sections stained conventionally with Hematoxylin & Eosin (H&E) or subjected to immunohistochemistry reagents to assist pathologists in making decisions that may contribute to the clinical management of cancer. With the advent of fast scanners that generate digital images of tissue slides, the workflow of the pathology laboratory can be enhanced in a cost effective manner by leveraging the advantages of digital images for both quantitative and semi-quantitative analyses. As the number of cases and resulting tissue samples requiring evaluation by pathologists increases, and the number of diagnostic tests deployed for grading and other tests for cancer grows, the use of digital pathology technologies, like the NEC e-Pathologist, become an important component of improved patient care. NEC has been developing the e-Pathologist Cancer Diagnosis Assistance System since 2003 by adapting its advanced image analysis, recognition and machine learning technologies which were developed in NEC's Central Research Laboratory and its North American laboratory (NEC Laboratories America). In October 2008, MGH and NEC entered into a collaboration to adapt modules of e-Pathologist to meet clinical needs in the pathological diagnosis of breast and prostate cancers. Sample slides were used to teach the e-Pathologist modules to capture important image features linked to disease. The e-Pathologist modules being installed at MGH target breast tissues and perform (1) detection of ROI (Region Of Interest) based on features of potentially cancerous areas observed in H&E stained slide images, and (2) selection and counting of target cells used in ER, PR and Her-2 tests from specially stained slides. MGH scientists, with help from NEC researchers and engineers, will evaluate e-Pathologist functions, and study an advanced pathology workflow in which the e-Pathologist system is expected to have an important role in overall diagnostic performances. "MGH has long been a leader in medical innovations, and MGH Pathology has long been committed to utilizing imaging and data analysis for diagnosis and discovery. Digital pathology is obviously an important development in driving such innovation. We are pleased to start the evaluation of the NEC e-Pathologist system at our site," said Dr. David Louis, Chief of Pathology at MGH. "NEC is proud of working with MGH as a partner in the realization of core tools for digital pathology," said Dr. Botaro Hirosaki, Senior Executive Vice President and Member of the Board, NEC. "The integration of MGH's pathology and medical imaging know-how with NEC's computer science and IT capabilities will make important innovations to the pathology information field possible." MGH and NEC will also work together to adapt e-Pathologist for analyzing prostate tissues. After on-site evaluation, NEC will continue to prepare the e-Pathologist system for use in the clinic. About NEC Corporation NEC Corporation is one of the world's leading providers of Internet, broadband network and enterprise business solutions dedicated to meeting the specialized needs of a diversified global base of customers. NEC delivers tailored solutions in the key fields of computer, networking and electron devices, by integrating its technical strengths in IT and Networks, and by providing advanced semiconductor solutions through NEC Electronics Corporation. The NEC Group employs more than 140,000 people worldwide. For additional information, please visit the NEC website at: http://www.nec.com. NEC is a registered trademark of NEC Corporation. All Rights Reserved. Other product or service marks mentioned herein are the trademarks of their respective owners. (C)2009 NEC Corporation. SOURCE: NEC Corporation Japan: NEC Corporation Chris Shimizu, +81-3-3798-6511 yc-shimizu@cb.jp.nec.com For full details for NIPNY click here.
Email Print Archives Feedback Email Article Link
Close X
Related News [NIPNY]
UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday December 3 12:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.
The TradingMarkets Directory
Stocks
Options
Forex
E-mini/Futures
How to Trade
Tools
PowerRatings
Blogs
Premium Subscription Services
RELATED SITES
Please call 1-213-955-5858 ext. 1
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN. The Connors Group, Inc. © Copyright 2009 The Connors Group, Inc. All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy. © 2009 The Connors Group, Inc.
|
